A previous report from Li revealed that EGCG suppressed epithelial–mesenchymal transition and migration by blocking TGF-β/Smad-signaling pathways and downregulation of Vimentin in anaplastic-thyroid-carcinoma (ATC) 8505 C cells [31]. The gene discussed is VIM; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.